Puma Biotechnology, Inc. (PBYI)
7.12
-0.14
(-1.93%)
USD |
NASDAQ |
May 08, 09:33
Puma Biotechnology Research and Development Expense (Annual) : 62.07M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Rigel Pharmaceuticals, Inc. | 33.30M |
| Agios Pharmaceuticals, Inc. | 334.36M |
| Editas Medicine, Inc. | 84.68M |
| Trevi Therapeutics, Inc. | 33.48M |
| Phathom Pharmaceuticals, Inc. | 32.78M |